User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
  Citation Number 1
 Views 48
 Downloands 5
İLAÇ SEKTÖRÜ ÜZERİNE BİR ÇALIŞMA: KAN SULANDIRICI İLAÇLARIN AHP YÖNTEMİ İLE SEÇİMİ
2021
Journal:  
Journal of Research in Business
Author:  
Abstract:

İlaç sektörü en hızlı büyüyen sektörlerden biridir. Farklı firmaların benzer içeriklerle çıkardığı ilaçlar arasında bu büyüme ile birlikte rekabet artmaktadır. Bu nedenle, ilaçların reçete edilmesinde uzmanlar tarafından doğru kriterlerin göz önüne alınması ve bu yönde bir sıralama yapılması, hem hastaların çıkarlarını korumak hem de adaletli davranabilmek adına çok önemlidir. Çalışmada, bir Çok Kriterli Karar Verme (ÇKKV) yöntemi olan Analitik Hiyerarşi Prosesi (Analytical Hierarchy Process / AHP) tekniği kullanılarak piyasada bulunan farklı kan sulandırıcı ilaç alternatifleri değerlendirilmiştir. Çalışmada uzman olarak danışılan, üniversite hastanesinde görev yapmakta olan bir kardiyolog doktorun değerlendirmelerine göre kan sulandırıcı ilaçların sıralamasında göz önüne alınan en önemli kriterler ilacın fiyatı, ulaşılabilirliği, ilaç hakkındaki güncel çalışmalar, hastaların takip kolaylığı ve ilacın hastalar açısından kullanım kolaylığıdır. Kriterlerin ağırlıkları belirlenmiş ve en önde gelen kriterin güncel çalışmalar, en az ağırlığa sahip kriterin ise ilacın fiyatı olduğu görülmüştür. Kriter ağırlıklarının elde edilmesinin ardından her ölçüt açısından alternatiflerin ağırlıkları/puanları belirlenmiştir. Puan matrislerinin kriter ağırlığı matrisi ile çarpılması sonucunda nihai alternatif puanlarına ulaşılmıştır. Sonuçlara göre, bu kriterler göz önüne alındığında en önde gelen seçenek Riveroxaban’dır. En son seçenek ise Clexane olmaktadır.

Keywords:

A change in the pharmaceutical sector: the choice of blood-sugaring drugs with the AHP method
2021
Author:  
Abstract:

The pharmaceutical industry is one of the fastest growing industries. The competition between the drugs that different companies produce with similar content is increasing with this growth. Therefore, it is very important that the proper criteria are taken into account by experts in the prescription of medications and that a ranking in this direction is made to protect both the interests of the patients and to be able to behave fairly. The study assessed the different blood-sweating medication alternatives available on the market using the Technique of Analytical Hierarchy Process (AHP), a Multi-Critical Decisioning Method. According to the assessments of a cardiologist who was consulted as a specialist in the study, the most important criteria taken into consideration in the ranking of blood-sweating drugs are the price of the drug, availability, current studies on the drug, the ease of patient tracking and the ease of use of the drug in terms of patients. The weight of the criteria has been determined and the most prominent criteria have been present studies, and the criteria with the lowest weight has been found to be the price of the drug. After the achievement of the criterion weights, the weights/points of the alternatives are determined for each criterion. The criterion weight of the matrix is matched with the criterion weight matrix and the final alternative points are achieved. According to the results, the top option when taking into account these criteria is Riveroxaban. The last option is Clexane.

Keywords:

0
2021
Author:  
Abstract:

Pharmaceutical industry is one of the fastest growing sectors. Rivalry among the pharmaceutical companies gets harder as the sector grows and different companies release drugs with the same active substances. That’s why, during the prescription process; consideration of the right criteria by the experts and sorting of different drugs accordingly are critical not only to protect interests of the patients but also to act fairly. In this study, various anti-coagulant drugs are evaluated by using Analytical Hierarchy Process (AHP) method which is among Multiple Criteria Decision Making (MCDM) techniques. According to the information we get from a cardiologist as an expert, the most important criteria for the sorting of anti-coagulant drugs are the price, attainability, current studies about the drug, complexity of the follow-up process and the ease of using the drug. Considering the relative weights of the criteria in terms of their importance, the most critical criterion is determined as the current studies about the drug, while the least important one is the price of the drug. After the weights of the criteria are identified; the weights of the alternative drugs are determined. After normalization, final results are attained. According to the results, the most convenient alternative is Riveroxaban, while the least convenient one is Clexane.

Keywords:

Citation Owners
Attention!
To view citations of publications, you must access Sobiad from a Member University Network. You can contact the Library and Documentation Department for our institution to become a member of Sobiad.
Off-Campus Access
If you are affiliated with a Sobiad Subscriber organization, you can use Login Panel for external access. You can easily sign up and log in with your corporate e-mail address.
Similar Articles






Journal of Research in Business

Journal Type :   Uluslararası

Metrics
Article : 167
Cite : 132
2023 Impact : 0.171
Journal of Research in Business